This panel will address current and emerging challenges surrounding such methods and new products from the business, legal, and regulatory perspectives. Topics will include the vaping crisis, regulation of novel delivery systems, hardware inputs and related supply chain matters, various approaches to the regulation of edibles, hemp, and hemp-derived CBD, and what the future may hold.
This panel will cover not only the law and current developments, but also offer practical advice for traveling, consuming, and securing privilege while practicing cannabis law.
Join us for an update - from the comments that INCBA has submitted to the CDFA on behalf of the industry, to the most important aspects of the regulations, and what is necessary to make appellations of origin a functional tool for consumer education and choice in the cannabis industry.
This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate hemp-derived CBD products.
Learn what is expected of you from the California Agencies, and use that as a template for your reopening no matter the jurisdictions. From providing PPE to social distancing, and spanning the obligations to your employees, customers, and the public at large, come to learn how to avoid liability and reopen safely and in accordance with the law.
Learn how to advise your clients to avoid additional scrutiny on the front end, how to prepare for an audit, and how to position your client for success post-audit. The panel will also take a look at novel state-level tax issues, such as a potency tax, and how that changes the bottom line for our clients.
Hear from the panel about what “also advise” means in practice, including what federal laws are considered “related,” how to determine if federal law “conflicts” with what your client seeks to do, and how to ensure you have adequately advised your client to comply with the new Rule 1.2 provision.
This panel will discuss, among other things: (i) the goals of implementing solid corporate governance infrastructure including transparency, equity among shareholders, and maintaining the integrity and legitimacy of a cannabis company in particular; (ii) the importance of advising clients about best practices for effectively maintaining and enforcing corporate governance systems by, including, but not limited to, adhering to the often-overlooked federal guidelines from the United States Sentencing Commission; and (iii) the importance of implementing corporate governance controls and policies during a company’s infancy; and (iv) lessons learned from high-profile cannabis companies whose poor corporate governance practices had a damaging impact, including companies like Namaste Technologies.
This panel will discuss the tactics states have adopted to keep people of color out of the industry along with resolutions. Attendees will leave the session knowledgeable about current equity policy impacts not only on retailers and indoor grow operations but rural communities of color.